These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1125 related articles for article (PubMed ID: 33500720)

  • 1. m
    Chong W; Shang L; Liu J; Fang Z; Du F; Wu H; Liu Y; Wang Z; Chen Y; Jia S; Chen L; Li L; Chen H
    Theranostics; 2021; 11(5):2201-2217. PubMed ID: 33500720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive analysis of m
    Liu T; Li H; Du G; Ma J; Shen J; Zhao H; Luo F; Li H
    Gene; 2022 May; 821():146250. PubMed ID: 35151825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. m
    Zhang B; Wu Q; Li B; Wang D; Wang L; Zhou YL
    Mol Cancer; 2020 Mar; 19(1):53. PubMed ID: 32164750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The significance of m6A RNA methylation modification in prognosis and tumor microenvironment immune infiltration of cervical cancer.
    Guo Y; Bai Y; Wang L; Xu Z; Wang X; Wang W
    Medicine (Baltimore); 2022 Jul; 101(26):e29818. PubMed ID: 35777046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive landscape of m6A regulator-related gene patterns and tumor microenvironment infiltration characterization in gastric cancer.
    Peng B; Lin Y; Yi G; Lin M; Xiao Y; Qiu Y; Yao W; Zhou X; Liu Z
    Sci Rep; 2024 Jul; 14(1):16404. PubMed ID: 39013954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of m
    Du F; Li H; Li Y; Liu Y; Li X; Dang N; Chu Q; Yan J; Fang Z; Wu H; Zhang Z; Zhu X; Li X
    Front Cell Dev Biol; 2021; 9():761134. PubMed ID: 34993195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. m
    Sun M; Xie M; Zhang T; Wang Y; Huang W; Xia L
    Front Immunol; 2021; 12():739768. PubMed ID: 34616403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. m6A regulator-mediated methylation modification patterns and tumor microenvironment infiltration characterization in hepatocellular carcinoma.
    Huang X; Qiu Z; Li L; Chen B; Huang P
    Aging (Albany NY); 2021 Aug; 13(16):20698-20715. PubMed ID: 34461607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation analysis of m6A-modified regulators with immune microenvironment infiltrating cells in lung adenocarcinoma.
    Ye W; Huang T
    PLoS One; 2022; 17(2):e0264384. PubMed ID: 35196365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristic of molecular subtypes in lung adenocarcinoma based on m6A RNA methylation modification and immune microenvironment.
    Zhou H; Zheng M; Shi M; Wang J; Huang Z; Zhang H; Zhou Y; Shi J
    BMC Cancer; 2021 Aug; 21(1):938. PubMed ID: 34416861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-talk of four types of RNA modification writers defines tumor microenvironment and pharmacogenomic landscape in colorectal cancer.
    Chen H; Yao J; Bao R; Dong Y; Zhang T; Du Y; Wang G; Ni D; Xun Z; Niu X; Ye Y; Li HB
    Mol Cancer; 2021 Feb; 20(1):29. PubMed ID: 33557837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of Novel m6A Regulator-mediated Methylation Modification Patterns in Distinct Tumor Microenvironment Profiles to Identify and Predict Glioma Prognosis and Progression, T-cell Dysfunction, and Clinical Response to ICI Immunotherapy.
    Zhao B; Xiang Z; Wu B; Zhang X; Feng N; Wei Y; Zhang W
    Curr Pharm Des; 2023; 29(1):60-78. PubMed ID: 36503445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of m
    Zhu M; Cui Y; Mo Q; Zhang J; Zhao T; Xu Y; Wu Z; Sun D; Zhang X; Li Y; You Q
    Front Immunol; 2021; 12():782551. PubMed ID: 34975871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Non-N
    Xu J; Gao Z; Liu K; Fan Y; Zhang Z; Xue H; Guo X; Zhang P; Deng L; Wang S; Wang H; Wang Q; Zhao R; Li G
    Front Immunol; 2021; 12():809808. PubMed ID: 35154083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autophagy-related gene expression classification defines three molecular subtypes with distinct clinical and microenvironment cell infiltration characteristics in colon cancer.
    Zhu S; Wu Q; Zhang B; Wei H; Li B; Shi W; Fang M; Zhu S; Wang L; Lang Zhou Y; Dong Y
    Int Immunopharmacol; 2020 Oct; 87():106757. PubMed ID: 32769067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. m6A regulator-mediated methylation modification patterns and characteristics of immunity and stemness in low-grade glioma.
    Du J; Ji H; Ma S; Jin J; Mi S; Hou K; Dong J; Wang F; Zhang C; Li Y; Hu S
    Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33594424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. m6A Regulators Mediated Methylation Modification Patterns and Tumor Microenvironment Infiltration Characterization In Nasopharyngeal Carcinoma.
    Liu Z; He J; Han J; Yang J; Liao W; Chen N
    Front Immunol; 2021; 12():762243. PubMed ID: 35069534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. m6A Regulator-Mediated Methylation Modification Patterns and Tumor Microenvironment Cell-Infiltration Characterization in Head and Neck Cancer.
    Yang Q; Xu F; Jian A; Yu H; Ye T; Hu W
    Front Cell Dev Biol; 2021; 9():803141. PubMed ID: 35198565
    [No Abstract]   [Full Text] [Related]  

  • 19. Integrated analyses of m
    Gao Y; Wang H; Li H; Ye X; Xia Y; Yuan S; Lu J; Xie X; Wang L; Zhang J
    Oncoimmunology; 2021 Jun; 10(1):1936758. PubMed ID: 34221700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-omics analysis of m
    Wu X; Bai Z
    Sci Rep; 2021 Oct; 11(1):20921. PubMed ID: 34686691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 57.